Man 1-2 Man-PEGylated Derivative as a Tool for in vitro and in vivo Dendritic Cell Targeting
The approach:ΓÇóIs highly cost effective and is capable of operating at a much larger scaleΓÇóAllows for a higher percentage of specific binding as compared to prior-art proceduresΓÇóAllows for an improved delivery of compounds as compared to conventional approachesΓÇóTriggers a desired response in dendritic cells, leading to their timely activationΓÇóAllows for an effective regulation of the immune system as compared to conventional approachesΓÇóUses liposomes that are stable and slightly negatively charged as compared to conventional approachesΓÇóWould be commercially useful for treating various disorders such as HIV, HBV, HCV, herpes viruses, autoimmune disorders, transplant rejection, and cancer
None
美国
